GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gaush Meditech 2407.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

4.60

+3.37%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.38bn

FY2019FY2025

Net income

CN¥96.2m

FY2019FY2025

Free cash flow

CN¥110.5m

FY2019FY2025

Shareholders' equity

CN¥1.69bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueCN¥1.38bnCN¥1.22bnCN¥1.20bnCN¥1.07bnCN¥1.11bnCN¥823.0mCN¥946.6m
Gross profitCN¥633.2mCN¥567.5mCN¥591.6mCN¥534.9mCN¥521.3mCN¥373.1mCN¥395.2m
Research and developmentCN¥92.6mCN¥67.1mCN¥45.2mCN¥35.1mCN¥20.1mCN¥2.7mCN¥2.3m
Operating incomeCN¥121.6mCN¥168.7mCN¥238.8mCN¥210.6mCN¥219.9mCN¥155.8mCN¥152.0m
Net incomeCN¥96.2mCN¥79.0mCN¥148.4m−CN¥299.1m−CN¥162.9mCN¥85.0m−CN¥31.7m
Diluted earnings per share0.670.541.00-3.00-1.140.59-0.22

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsCN¥2.63bnCN¥2.57bnCN¥2.84bnCN¥2.72bnCN¥2.08bnCN¥1.91bnCN¥880.2m
Cash and short-term investmentsCN¥440.9mCN¥519.0mCN¥833.0mCN¥814.2mCN¥520.9mCN¥263.0mCN¥171.2m
Total liabilitiesCN¥921.7mCN¥978.1mCN¥1.15bnCN¥1.23bnCN¥2.62bnCN¥1.87bnCN¥674,054
DebtCN¥507.4mCN¥552.2mCN¥664.4mCN¥756.0mCN¥2.24bnCN¥1.49bnCN¥596.9m
Shareholders' equityCN¥1.69bnCN¥1.58bnCN¥1.68bnCN¥1.47bn−CN¥561.5mCN¥21.9m−CN¥69.6m
Shares outstanding144m148m148m100m143m143m143m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operationsCN¥144.2mCN¥92.2mCN¥213.0mCN¥234.4mCN¥140.7mCN¥111.2mCN¥146.3m
Capital spending−CN¥33.8m−CN¥69.5m−CN¥39.0m−CN¥48.0m−CN¥24.0m−CN¥1.6m−CN¥3.5m
Free cash flowCN¥110.5mCN¥22.7mCN¥174.0mCN¥186.4mCN¥116.7mCN¥109.6mCN¥142.9m
Dividends paid—−CN¥127.1m—————

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
RevenueCN¥595.8mCN¥727.3mCN¥653.1mCN¥672.7mCN¥393.2mCN¥549.2mCN¥321.0mCN¥603.5m
Gross profitCN¥288.7mCN¥317.5mCN¥315.7mCN¥312.3mCN¥182.5mCN¥255.2mCN¥149.2mCN¥281.4m
Operating incomeCN¥43.4mCN¥50.3mCN¥71.4mCN¥113.3mCN¥66.2mCN¥63.4mCN¥37.1mCN¥93.4m
Net incomeCN¥17.3mCN¥58.2mCN¥38.0mCN¥54.7mCN¥32.0mCN¥24.4mCN¥14.2mCN¥53.2m
Diluted earnings per share0.120.400.260.370.220.160.100.36
Cash from operations—CN¥111.0mCN¥23.0mCN¥101.0m—−CN¥9.0m−CN¥5.0mCN¥117.0m
Capital spending—−CN¥12.0m−CN¥10.0m−CN¥6.0m—−CN¥6.0m−CN¥3.0m−CN¥25.0m
Free cash flow—CN¥99.0mCN¥13.0mCN¥95.0m—−CN¥15.0m−CN¥8.0mCN¥92.0m
Total assetsCN¥2.45bnCN¥2.63bnCN¥2.57bnCN¥2.57bnCN¥2.57bnCN¥2.40bnCN¥2.81bnCN¥2.43bn
Cash and short-term investmentsCN¥358.1mCN¥440.9mCN¥383.7mCN¥519.0mCN¥519.0mCN¥645.1mCN¥754.2mCN¥712.6m
DebtCN¥136.5mCN¥465.2mCN¥469.1mCN¥527.9mCN¥190.8mCN¥535.2mCN¥238.9mCN¥568.3m
Shareholders' equityCN¥1.65bnCN¥1.69bnCN¥1.66bnCN¥1.58bnCN¥1.58bnCN¥1.32bnCN¥1.54bnCN¥1.44bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.8%10.9%—
Operating income-16.7%-4.8%—
Net income—2.5%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin46.1%47.7%47.3%—
Operating margin11.2%15.2%16.4%—
Net margin6.7%0.5%-0.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings10.415.932.6-14.9
Price to sales0.71.04.04.2

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 23 Jun 2025.

FY2025FY2024
Paid in the year0.301.10

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.